E10K (p.Glu10Lys) variant of ABL2 (Tyrosine-protein kinase ABL2)
E10K (p.Glu10Lys) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.51 / 1. The record also includes population frequency data.
E10K (p.Glu10Lys) variant details
- p.Glu10Lys
- NCI-TCGA Cosmic COSV6266
- Variant assessed as somatic; high impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.506
- REVEL 0.36
- CADD 23.90
- PolyPhen-2 0.02
- SIFT 0.01
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available